These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27181229)

  • 1. [Prognosis and progress in immunotherapies for organ involvements in systemic autoimmune diseases].
    Yasuda S; Kono M; Shimamura S; Kurita T; Odani T; Atsumi T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):8-17. PubMed ID: 27181229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil as a therapeutic agent for interstitial lung diseases in systemic sclerosis.
    Ueda T; Sakagami T; Kikuchi T; Takada T
    Respir Investig; 2018 Jan; 56(1):14-20. PubMed ID: 29325675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial lung disease in systemic sclerosis.
    Bussone G; Mouthon L
    Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of systemic sclerosis-associated interstitial lung disease.
    Roofeh D; Jaafar S; Vummidi D; Khanna D
    Curr Opin Rheumatol; 2019 May; 31(3):241-249. PubMed ID: 30870216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience of mycophenolate mofetil in 10 patients with autoimmune-related interstitial lung disease demonstrates promising effects.
    Saketkoo LA; Espinoza LR
    Am J Med Sci; 2009 May; 337(5):329-35. PubMed ID: 19295413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
    Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of systemic sclerosis-associated interstitial lung disease].
    Prasse A; Bonella F; Müller-Ladner U; Witte T; Hunzelmann N; Distler J
    Z Rheumatol; 2020 Apr; 79(3):294-303. PubMed ID: 31754786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus.
    Sumida H; Asano Y; Tamaki Z; Aozasa N; Taniguchi T; Takahashi T; Toyama T; Ichimura Y; Noda S; Akamata K; Miyazaki M; Kuwano Y; Yanaba K; Sato S
    J Dermatol; 2014 May; 41(5):418-20. PubMed ID: 24801917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.
    Rosen O; Thiel A; Massenkeil G; Hiepe F; Häupl T; Radtke H; Burmester GR; Gromnica-Ihle E; Radbruch A; Arnold R
    Arthritis Res; 2000; 2(4):327-36. PubMed ID: 11056673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M
    Curr Opin Rheumatol; 2011 Sep; 23(5):454-8. PubMed ID: 21720247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot trial for severe, refractory systemic autoimmune disease with stem cell transplantation.
    Leng XM; Zhao Y; Zhou DB; Situ H; Li TS; Shen T; Zhao YQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Chin Med Sci J; 2005 Sep; 20(3):159-65. PubMed ID: 16261884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
    Cohen Y; Nagler A
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):865-7. PubMed ID: 12455162
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus.
    Tyndall A
    J Rheumatol Suppl; 1997 May; 48():94-7. PubMed ID: 9150127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective.
    Hough RE; Snowden JA; Wulffraat NM
    Br J Haematol; 2005 Feb; 128(4):432-59. PubMed ID: 15686452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycophenolate mofetil in the treatment of selected connective tissue diseases].
    Batko B; Krawiec P; Osieleniec J; Sułowicz W
    Przegl Lek; 2013; 70(9):724-9. PubMed ID: 24455833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cell therapy in autoimmune diseases].
    Farge-Bancel D
    Rev Med Interne; 2011 Dec; 32 Suppl 2():S204-7. PubMed ID: 22056080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.